Moreover, T cells from AML patients also displayed significantly higher expression of activation (CD69, HLA-DR) and exhaustion (PD1, LAG3) markers compared to healthy donors (Figures 1C, S2). The gene discussed is LAG3; the disease is acute myeloid leukemia.